VLP Purification Patent granted in US

ARTES is pleased to announce the enlarge­ment of the pro­tec­tive aera for their VLP devel­op­ment  and pro­duc­tion plat­form patent . The patent is about a “Method for Sep­a­rat­ing of Virus­like Par­ti­cles from a Cell Sus­pen­sion” and now valid in Europe and US.

VLP purification patent granted in EU

Artes is pleased to announce the issuance of a new patent for their VLP devel­op­ment  and pro­duc­tion plat­form. The patent is about a “Method for Sep­a­rat­ing of Virus­like Par­ti­cles from a Cell Suspension”. 

ARTES and Burnet Institute publish data on new malaria vaccine candidates

For more infor­ma­tion: Nov­el Virus-Like Par­ti­cle Vac­cine Encod­ing the Cir­cum­sporo­zoite Pro­tein of Plas­mod­i­um fal­ci­parum Is Immuno­genic and Induces Func­tion­al Anti­body Respons­es in Mice.